{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:30:37Z","timestamp":1785475837664,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Topical antimicrobials are recommended for first line treatment of surface and superficial infections in dogs. This is especially important given the increasing prevalence of antimicrobial resistant infections. Antimicrobial wipes have become popular, but there are a lack of controlled studies assessing their in vitro antimicrobial and in vivo residual activity. We aimed to assess the antimicrobial efficacy of two commercial antimicrobial wipes against frequently isolated pathogens.<\/jats:p><jats:p>Ten clinical and one reference isolate each of meticillin-susceptible<jats:italic>Staphylococcus pseudintermedius<\/jats:italic>(MSSP), meticillin-resistant<jats:italic>S. pseudintermedius<\/jats:italic>(MRSP),<jats:italic>Escherichia coli<\/jats:italic>(EC), extended spectrum beta-lactamase (ESBL) producing<jats:italic>E. coli<\/jats:italic>(ESBL-EC),<jats:italic>Pseudomonas aeruginosa<\/jats:italic>(PA) and<jats:italic>Malassezia pachydermatis<\/jats:italic>(MP) were tested using a modified Kirby-Bauer technique. Each isolate was tested against 6\u2009mm discs of chlorhexidine (CHX) and acetic acid\/boric acid (AABA) wipes, and positive and negative controls either overnight (bacteria) or for 3\u2009days (<jats:italic>Malassezia<\/jats:italic>).<\/jats:p><jats:p>Healthy dogs were treated with the wipes and distilled water on a randomised flank (<jats:italic>n<\/jats:italic>\u2009=\u20095 each). Hair samples (1\u2009cm; 0.1\u2009g) taken at days 0, 1 and 3 were inoculated with an isolate of each organism. Zones of inhibition (ZI) were measured.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All isolates produced confluent growth with AABA and control wipes, except for the cleansing wipes and MP (median ZI 12\u2009mm; 95% CI 8.2\u201315.8). The median (95% CI) CHX wipe ZIs (mm) were: MP 48.0 (47.0\u201349.0), MSSP 15.6 (14.2\u201317.0), MRSP 14.0 (13.6\u201314.4), EC 13.6 (12.0\u201315.2) and ESBL-EC 10.0 (9.4\u201310.6). PA showed confluent growth. The differences between the bacterial isolates was significant (Kruskal-Wallis<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001; post-tests MSSP\u2009=\u2009MRSP\u2009=\u2009EC\u2009&gt;\u2009EBSL-EC\u2009&gt;\u2009PA). Confluent growth was visible with all the hair samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CHX but not AABA showed in vitro efficacy against MSSP, MRSP, EC and MP. ESBL-EC were less susceptible and there was no activity against PA. There was no residual activity on hair. Additional studies are required to determine efficacy of these products in clinically affected patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-019-2098-z","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:44:07Z","timestamp":1572468247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A pilot study of the in vitro antimicrobial activity and in vivo residual activity of chlorhexidine and acetic acid\/boric acid impregnated cleansing wipes"],"prefix":"10.1186","volume":"15","author":[{"given":"Rebecca","family":"Rafferty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-6004","authenticated-orcid":false,"given":"Victoria H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally A.","family":"Argyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Nuttall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"2098_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/vr.101070","volume":"172","author":"L Beco","year":"2013","unstructured":"Beco L, Guaguere E, Lorente Mendez C, Noli C, Nuttall T, Vroom M. Suggested guidelines for using systemic antimicrobials in bacterial skin infections (2): antimicrobial choice, treatment regimens and compliance. Vet Rec. 2013;172:156\u201360.","journal-title":"Vet Rec."},{"key":"2098_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/vde.12118","volume":"25","author":"A Hillier","year":"2014","unstructured":"Hillier A, Lloyd DH, Weese JS, Blondeau JM, Boothe D, Breitschwerdt E, Guardabassi L, Papich M, Rankin S, Turnidge JD, Sykes JE. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (antimicrobial guidelines working Group of the International Society for companion animal infectious diseases). Vet Dermatol. 2014;25:163\u2013e43.","journal-title":"Vet Dermatol"},{"key":"2098_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1053\/j.ctsap.2006.05.003","volume":"21","author":"W Rosenkrantz","year":"2006","unstructured":"Rosenkrantz W. Practical applications of topical therapy for allergic, infectious, and Seborrheic disorders. Clin Tech Small Anim Pract. 2006;21:106\u201316.","journal-title":"Clin Tech Small Anim Pract"},{"key":"2098_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/vde.12220","volume":"26","author":"P Cavana","year":"2015","unstructured":"Cavana P, Peano A, Petit J-Y, Tizzabi P, Perrot S, Bensignor E, Guillot J. A pilot study of the efficacy of wipes containing chlorhexidine 0.3%, climbazole 0.5% and Tris-EDTA to reduce Malassezia pachydermatis populations on canine skin. Vet Dermatol. 2015;26:278\u2013e261.","journal-title":"Vet Dermatol"},{"key":"2098_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1099\/ijs.0.63413-0","volume":"55","author":"LA Devriese","year":"2005","unstructured":"Devriese LA, Vancanneyt M, Baele M, Vaneechoutte M, De Graef E, Snauwaert C, Cleenwerck I, Dawyndt P, Swings J, Decostere A, Haesebrouck F. Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int J Syst Evol Microbiol. 2005;55:1569\u201373.","journal-title":"Int J Syst Evol Microbiol"},{"key":"2098_CR6","first-page":"730","volume":"42","author":"M Fortin","year":"2001","unstructured":"Fortin M, Higgins R. Mixed infection associated with a group B Streptococcus in a dog. Can Vet J. 2001;42:730.","journal-title":"Can Vet J"},{"key":"2098_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-3164.2006.00550.x","volume":"17","author":"A Hillier","year":"2006","unstructured":"Hillier A, Alcorn JR, Cole LK, Kowalski JJ. Pyoderma caused by Pseudomonas aeruginosa infection in dogs: 20 cases. Vet Dermatol. 2006;17:432\u20139.","journal-title":"Vet Dermatol"},{"key":"2098_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12917-014-0240-5","volume":"10","author":"JF Summers","year":"2014","unstructured":"Summers JF, Hendricks A, Brodbelt DC. Prescribing practices of primary-care veterinary practitioners in dogs diagnosed with bacterial pyoderma. BMC Vet Res. 2014;10:240\u201350.","journal-title":"BMC Vet Res"},{"key":"2098_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-3164.2005.00424.x","volume":"16","author":"T Chen","year":"2005","unstructured":"Chen T, Hill PB. The biology of Malassezia organisms and their ability to induce immune responses and skin disease. Vet Dermatol. 2005;16:4\u201326.","journal-title":"Vet Dermatol"},{"key":"2098_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1748-5827.1996.tb02353.x","volume":"37","author":"R Bond","year":"1996","unstructured":"Bond R, Ferguson EA, Curtis CF, Craig JM, Lloyd DH. Factors associated with elevated cutaneous Malassezia pachydermatis populations in dogs with pruritic skin disease. J Small Anim Pract. 1996;37:103\u20137.","journal-title":"J Small Anim Pract"},{"key":"2098_CR11","doi-asserted-by":"crossref","unstructured":"Moore SL, Payne DN. Types of Antimicrobial Agents In: Fraise AP, A. LP,Maillard J-Y, eds. Russell, Hugo & Ayliffe's Principles and Practice of Disinfection, Preservation & Sterilization. 4th edition. Oxford, UK: Blackwell Publishing Ltd. 2004; 8\u201397.","DOI":"10.1002\/9780470755884.ch2"},{"key":"2098_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/CMR.12.1.147","volume":"12","author":"G McDonnell","year":"1999","unstructured":"McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147\u201379.","journal-title":"Clin Microbiol Rev"},{"key":"2098_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/vde.12357","volume":"27","author":"SM Clark","year":"2016","unstructured":"Clark SM, Loeffler A, Schmidt VM, Chang Y-M, Wilson A, Timofte D, Bond R. Interaction of chlorhexidine with trisEDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions. Vet Dermatol. 2016;27:340\u2013e384.","journal-title":"Vet Dermatol"},{"key":"2098_CR14","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/jac\/dkv056","volume":"70","author":"SM Clark","year":"2015","unstructured":"Clark SM, Loeffler A, Bond R. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma. J Antimicrob Chemother. 2015;70:2048\u201352.","journal-title":"J Antimicrob Chemother"},{"key":"2098_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/vr.d4400","volume":"169","author":"A Loeffler","year":"2011","unstructured":"Loeffler A, Cobb MA, Bond R. Comparison of a chlorhexidine and a benzoyl peroxide shampoo as sole treatment in canine superficial pyoderma. Vet Rec. 2011;169:249\u201353.","journal-title":"Vet Rec"},{"key":"2098_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1365-3164.2009.00812.x","volume":"21","author":"L Guardabassi","year":"2010","unstructured":"Guardabassi L, Ghibaudo G, Damborg P. In vitro antimicrobial activity of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA. Vet Dermatol. 2010;21:282\u20136.","journal-title":"Vet Dermatol"},{"key":"2098_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1365-3164.2011.00968.x","volume":"22","author":"N Murayama","year":"2011","unstructured":"Murayama N, Terada Y, Okuaki M, et al. Dose assessment of 2% chlorhexidine acetate for canine superficial pyoderma. Vet Dermatol. 2011;22:449\u201353.","journal-title":"Vet Dermatol"},{"key":"2098_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1136\/vr.100643","volume":"170","author":"S Viaud","year":"2012","unstructured":"Viaud S, Maynard L, Sanquer A. Comparison of two shampoos as sole treatment for canine bacterial overgrowth syndrome. Vet Rec. 2012;170:675.","journal-title":"Vet Rec"},{"key":"2098_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/vde.12233","volume":"26","author":"S Borio","year":"2015","unstructured":"Borio S, Colombo S, La Rosa G, De Lucia M, Damborg P, Guardabassi L. Effectiveness of a combined (4% chlorhexidine digluconate shampoo and solution) protocol in MRS and non-MRS canine superficial pyoderma: a randomized, blinded, antibiotic-controlled study. Vet Dermatol. 2015;26:339\u2013e72.","journal-title":"Vet Dermatol"},{"key":"2098_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-3164.2008.00713.x","volume":"19","author":"A Swinney","year":"2008","unstructured":"Swinney A, Fazakerley J, McEwan N, Nuttall T. Comparative in vitro antimicrobial efficacy of commercial ear cleaners. Vet Dermatol. 2008;19:373\u20139.","journal-title":"Vet Dermatol"},{"key":"2098_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-3164.2011.01002.x","volume":"23","author":"R Young","year":"2012","unstructured":"Young R, Buckley L, McEwan N, Nuttall T. Comparative in vitro efficacy of antimicrobial shampoos: a pilot study. Vet Dermatol. 2012;23:36\u2013e38.","journal-title":"Vet Dermatol"},{"issue":"2","key":"2098_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/09674845.2017.1278884","volume":"74","author":"AA Kadry","year":"2017","unstructured":"Kadry AA, Serry FM, El-Ganiny AM, El-Baz AM. Integron occurrence is linked to reduced biocide susceptibility in multidrug resistant Pseudomonas aeruginosa. Br J Biomed Sci. 2017;74(2):78\u201384.","journal-title":"Br J Biomed Sci"},{"issue":"3","key":"2098_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/vde.12306","volume":"27","author":"M Uri","year":"2016","unstructured":"Uri M, Buckley LM, Marriage L, McEwan N, Schmidt VM. A pilot study comparing in vitro efficacy of topical preparations against veterinary pathogens. Vet Dermatol. 2016;27(3):152\u2013e39.","journal-title":"Vet Dermatol"},{"key":"2098_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/vde.12048","volume":"24","author":"F Banovic","year":"2013","unstructured":"Banovic F, Bozic F, Lemo N. In vitro comparison of the effectiveness of polihexanide and chlorhexidine against canine isolates of Staphylococcus pseudintermedius, Pseudomonas aeruginosa and Malassezia pachydermatis. Vet Dermatol. 2013;24:409\u2013e89.","journal-title":"Vet Dermatol"},{"key":"2098_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/vde.12371","volume":"27","author":"G Ghibaudo","year":"2016","unstructured":"Ghibaudo G, Santospirito D, Sala A, Flisi S, Taddei S, Cavirani S, Cabassi CS. In vitro antimicrobial activity of a gel containing antimicrobial peptide AMP2041, chlorehexidine digluconate and Tris-EDTA on clinical isolates of Pseudomonas aeruginosa from canine otitis. Vet Dermatol. 2016;27:391\u2013e98.","journal-title":"Vet Dermatol"},{"issue":"5","key":"2098_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1469-0691.2009.02837.x","volume":"16","author":"M Grare","year":"2010","unstructured":"Grare M, Dibama HM, Lafosse S, Ribon A, Mourer M, Regnouf-de-Vains JB, Finance C, Duval RE. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine. Clin Microbiol Infect. 2010;16(5):432\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2098_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.diagmicrobio.2017.01.023","volume":"88","author":"D Deus","year":"2017","unstructured":"Deus D, Krischek C, Pfeifer Y, Sharifi AR, Fiegen U, Reich F, Klein G, Kehrenberg C. Comparative analysis of the susceptibility to biocide and heavy metals of extended-spectrum-\u03b2- lactamase-producing Escherichia coli isolates of human and avian origin. Germany Diagn Microbiol Infect Dis. 2017;88(1):88\u201392.","journal-title":"Germany Diagn Microbiol Infect Dis"},{"key":"2098_CR28","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/vde.12024","volume":"24","author":"CL Mason","year":"2013","unstructured":"Mason CL, Steen SI, Paterson S, Cripps PJ. Study to assess in vitro antimicrobial activity of nine ear cleaners against 50 Malassezia pachydermatis isolates. Vet Dermatol. 2013;24:362\u2013e81.","journal-title":"Vet Dermatol"},{"key":"2098_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1748-5827.2012.01262.x","volume":"53","author":"SI Steen","year":"2012","unstructured":"Steen SI, Paterson S. The susceptibility of Pseudomonas spp. isolated from dogs with otitis to topical ear cleaners. J Small Anim Prac. 2012;53:599\u2013603.","journal-title":"J Small Anim Prac"},{"key":"2098_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/vde.12318","volume":"27","author":"ML Mesman","year":"2016","unstructured":"Mesman ML, Kirby AL, Rosenkrantz WS, Griffen CE. Residual antibacterial activity of canine hair treated with topical antimicrobial sprays against Staphylococcus pseudintermedius in vitro. Vet Dermatol. 2016;27:261\u2013e261.","journal-title":"Vet Dermatol"},{"key":"2098_CR31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/vde.12012","volume":"24","author":"I Kloos","year":"2013","unstructured":"Kloos I, Straubinger RK, Werckenthin C, Mueller RS. Residual antibacterial activity of dog hairs after therapy with antimicrobial shampoos. Vet Dermatol. 2013;24:250\u20134.","journal-title":"Vet Dermatol"},{"issue":"3","key":"2098_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4103\/ijps.IJPS_245_16","volume":"50","author":"K Agrawal","year":"2017","unstructured":"Agrawal K, Sarda A, Shrotriya R, Bachhav M, Puri V, Nataraj G. Acetic acid dressings: finding the holy grail for infected wound management. India J Plast Surg. 2017;50(3):273\u201380.","journal-title":"India J Plast Surg"},{"key":"2098_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jhin.2013.05.001","volume":"84","author":"AP Fraise","year":"2013","unstructured":"Fraise AP, Wilkinson MAC, Bradley CR, Oppenheim B, Moiemen N. The antibacterial activity and stability of acetic acid. J Hosp Infect. 2013;84:329\u201331.","journal-title":"J Hosp Infect"},{"key":"2098_CR34","doi-asserted-by":"publisher","first-page":"e0136190","DOI":"10.1371\/journal.pone.0136190","volume":"10","author":"FD Halstead","year":"2015","unstructured":"Halstead FD, Rauf M, Moiemen NS, Bamford A, Wearn CM, Fraise AP, Lund PA, Oppenheim BA, Webber MA. The antibacterial activity of acetic acid against biofilm-producing pathogens of relevance to burns patients. PLoS One. 2015;10:e0136190.","journal-title":"PLoS One"},{"issue":"2","key":"2098_CR35","first-page":"1423","volume":"42","author":"MT Yilmaz","year":"2012","unstructured":"Yilmaz MT. Minimum inhibitory and minimum bactericidal concentrations of boron compounds against several bacterial strains. Turk J Med Sci. 2012;42(2):1423\u20139.","journal-title":"Turk J Med Sci"},{"key":"2098_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12011-016-0637-z","volume":"173","author":"Z Sayin","year":"2016","unstructured":"Sayin Z, Ucan US, Sakmanoglu A. Antibacterial and antibiofilm effects of boron on different bacteria. Biol Trace Elem Res. 2016;173:241\u20136.","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"2098_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/ice.2015.285","volume":"37","author":"A Boonyasiri","year":"2016","unstructured":"Boonyasiri A, Thaisiam P, Permpikul C, Judaeng T, Suiwongsa B, Apiradeewajeset N, Fakthongphan T, Suddee S, Laogtipparos W, Thamlikitkul V. Effectiveness of chlorhexidine wipes for the prevention of multidrug-resistant bacterial colonization and hospital-acquired infections in intensive care unit patients: a randomised trial in Thailand. Infect Control Hosp Epidermiol. 2016;37(3):245\u201353.","journal-title":"Infect Control Hosp Epidermiol"},{"issue":"4","key":"2098_CR38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1017\/ice.2019.20","volume":"40","author":"A Patel","year":"2019","unstructured":"Patel A, Parikh P, Dunn AN, Otter JA, Thota P, Fraser TG, Donskey CJ, Deshpande A. Effectiveness of daily chlorhexidine bathing for reducing gram-negative infections: a meta-analysis. Infect Control Hosp Epidemiol. 2019;40(4):392\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2098_CR39","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals - approved standard 3rd edition. CLSI document VET02-A3. 2008."},{"key":"2098_CR40","unstructured":"Clinical and Laboratory Standards Institute. Method for antifungal disk diffusion susceptibility testing of yeasts. 2nd edition. CLSI document M44. 2009."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2098-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-019-2098-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2098-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:51:39Z","timestamp":1664758299000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-019-2098-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1186\/s12917-019-2098-z","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"5 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Royal (Dick) School of Veterinary Studies Ethics committee. Informed written consent was granted from the owners of the dogs. Clinical isolates were selected from archived samples at the Royal (Dick) School of Veterinary Studies Microbiology service.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TJ Nuttall and VH Robinson have received unrelated support and\/or funding from ICF\u00ae and Dechra\u00ae Veterinary Products but the companies were not involved in the funding or the design of the study, and the authors have no financial or other interests in their products.The other authors report no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}